Cite
HARVARD Citation
Prabahran, A. et al. (2018). Prognostic markers in core‐binding factor AML and improved survival with multiple consolidation cycles of intermediate‐/high‐dose cytarabine. European journal of haematology. pp. 174-184. [Online].